Skip to main content

Closed

CRVS: Corvus Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

52W Range

40thpctl

Volume

0.52×avg

Market Cap

1.12BUSD

P/E Ratio

-24.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

Corvus Pharmaceuticals, Inc.

CRVSNASDAQ Global Market·USD·Closed

Corvus Pharmaceuticals, Inc.

CRVSNASDAQ·USD·Closed

$13.26

+0.53%

$13.26

+$0.07 (0.53%)

52W Range

40thpctl

Volume

0.52×avg

Mkt Cap

1.12BUSD

Rank

–cap

From ATH

–ath

Overview Sentiment

Overview Sentiment